Having gone through his own life-threatening, critical illness and being exposed to the ineffectiveness of modern medicine in his health care, Michael understands what it is like to be critically ill. This life experience has given him special insight into health and the commitment to keep improving his skills and therapies so that he may assist his patients in attaining their best possible levels of optimal health.
Michael’s accomplishments and experiences have truly made him an empathetic and resourceful Naturopathic Doctor. Keeping a watchful eye over every aspect of the clinic, Michael A. Prytula ND is the heart and soul of NaturoMedicTM.com Through his extensive and ongoing training, Michael has developed a very methodical approach to achieving optimal health.
Michael A. Prytula’s background includes:
He continues to improve his practice by continually updating, expanding and creating various therapies to remain on the cutting edge of new and improved modalities. He is thankful for the education provided to him by his patients. For one learns most when challenged by difficult cases.
In 1995 Michael A. Prytula ND witnessed a patient die from AIDS and others from cancer, therefore he searched for therapies with documented effectiveness and went abroad for training. Ozone training and certification was received in Lille, France.
In 1995 and 1996 he needed further training in effective therapeutics for cancer, heart disease and stroke. So again he went for training with Dr. Charles Farr MD, founding member of American College for the Advancement of Medicine (ACAM), International Bio-oxidative Medicine (IBOM) and International Society of Chelation Technicians (ISCT).
In 1997-98 he saw many patients who could only eat a few foods and others who reacted with severe allergic reactions. After researching effective therapies, he went for NAET training abroad with Dr. Devi Nambudripad and with others later on.
In 1999 he saw many patients with subconscious emotions inhibiting their healing, and producing undesirable behaviour. After researching effective therapies, he again went for training abroad – this time in Neuro Emotional Technique. He has created a more effective technique called Mental Reprogramming Technique (MRT).
In 2000-01 he discovered that Chronic Stealth Infections were the biggest factor challenging his patients with the most debilitating of diseases. So after researching again, he went abroad for effective training with JMT technique and with Dr. Dietrick Klinghart MD. He is now working on more effective techniques.
In 2001-02 Michael observed that Chemical Sensitivities and Toxic Industrial Diseases presented themselves in patients coming to see him for help. So again after researching, training from the world leaders (Dr. Walter Krinnion ND) in the field was needed.
In 2001 after taking many IV courses and seeing an absolute lack of training in Emergency IV Procedures, he conducted research and created his own course on “IV Worst Case Scenarios”. This course was well-received by his colleagues with 95% of attendees rating it as either very good or excellent in all categories.
IV courses researched and created by Michael A. Prytula, ND include: Emergency Procedures Course, Basic Intravenous Course, Ozone UV Blood and Hydrogen Peroxide Course, and Chelation and Ascorbates course. All courses are approved as prerequisites for practice by the Alberta Association of Naturopathic Physicians and are soon to be approved by other jurisdictions.
Whenever Michael A. Prytula,ND hits a roadblock with a patient not getting results, he inquires why, and does not stop questioning until he is getting successful repeatable results.
As of March 31,2022:
We are having mixed emotions in writing this. We have always excelled in our services and aspired to the highest heights of what our profession can deliver in trying to attain incredible healing for our patients and members while providing the safest of environments. We have just celebrated providing 27 years of ozone and chelation therapies in Ontario and many other milestones. In fact, we brought Naturopathic IV therapies to Ontario and made IV delivery safer across Canada, the United States, and Mexico by training many medical doctors, nurses and Naturopathic Doctors.
We wish this was an April fools joke but as of April 1, 2022 we will no longer be able to provide PMA service to our clients. Unfortunately, in spite of PMA members exercising their rights, their files along with our patient files were seized without the members or patients consent. In the summer of 2020, investigators arrived on our doorstep demanding patient files (there was no patient or member complaint to initiate this investigation). Until recently representatives of the Ministry of Health and other regulatory colleges needed a patient complaint and patient consent to demand a file. These files were given to the investigators however PMA members files were not given to them as PMA members exercised their fundamental rights under the Canadian Charter of Rights and Freedoms and the Canadian Bill of Rights. When denied the investigators returned in force with a search warrant and seven investigators accompanied by two police officers to ensure they could seize PMA members files. Upon threat of arrest Dr Prytula ND complied. They then took almost two years to build their case. Rather than deal with the issue in court they decided to try to do as much damage as they could to your rights by denying your access to services that you have relied upon to achieve and maintain your health goals. Dr Prytula ND and Dr Um ND have also been training and certifying doctors for these therapies across Canada since 2002. With courses approved by licencing boards in BC, Alberta, Saskatchewan, Manitoba, and Nova Scotia and by reciprocity most US States and Mexico. We as NDs have prescription rights in Ontario, but interestingly not in Alberta, and all the substances that are in question that are using in Ontario, Naturopathic Doctors can use freely without prescription rights, in Alberta. We have always restricted ourselves to performing PMA services that we are able to deliver in other jurisdictions. After 27 years of no patient complaints in regards to these services, we are no longer able to provide these very specialized services to you as we have been served with an interim order to stop all PMA services.
It is with great regret and heartbreak that we have had to comply with unaccountable bureaucrats who dont hold your rights in high regard or respect your health care decisions and preferences.
Dr Michael A Prytula ND and Dr Mike Um ND
As per CONO interim order:
The Registrant shall post a sign, acceptable to the College, a) in a prominent and visible location
in the waiting room and each of the examination/treatment rooms of the Registrant’s place(s) of
practice, and b) on the Registrant’s professional website, that states that:
o the Registrant is not authorized to perform, delegate, or accept delegation for the
controlled act of administering a substance by injection to any person, other than a
substance, in accordance with the limitations, specified in Table 2 of the General
Regulation made under the Naturopathy Act, 2007; and
o the College of Naturopaths of Ontario has imposed a Term, Condition and Limitation on
the Registrant’s certificate of registration in relation to administering a substance by
The Registrant shall ensure that every patient he treats or offers to treat, sign a form, acceptable
to the College, confirming that they are made aware that the Registrant is not authorized to
perform, delegate or accept delegation for the controlled acts of administering a substance by
injection to any person, other than a substance, in accordance with the limitations, specified in
Table 2 of the General Regulation made under the Naturopathy Act, 2007.
prescribed Substances that may be Administered by Injection
|Substance||Route of Administration||Limitation|
|Acetylcysteine||Intravenous||Must be in combination with other amino acids.|
|Adenosine triphosphate||Intravenous||No limitation specified.|
|Alanine||Intravenous||Must be in combination with other amino acids.|
|Arginine||Intravenous||Must be in combination with other amino acids.|
|Aspartic Acid||Intravenous||Must be in combination with other amino acids.|
|Atropine||Intravenous||Administered to a patient by the member in his or her office only in emergency circumstances. In an emergency, administer 0.5-1 mg q3-5 min. Dose must be 0.5 mg or higher but must not exceed 2 mg.|
|Biotin||Intravenous||No limitation specified.|
|Calcium Chloride||Intravenous||No limitation specified.|
|Calcium Gluconate||Intravenous||No limitation specified.|
|Calcium Glycerophosphate||Intravenous||No limitation specified.|
|Carbohydrates in sodium chloride solution||Intravenous||No limitation specified.|
|Chromium||Intravenous||No limitation specified.|
|Copper Sulfate||Intravenous||No limitation specified.|
|Cupric Chloride||Intravenous||No limitation specified.|
|Dextrose Injection||Intravenous||No limitation specified.|
|Diphenhydramine Hydrochloride||Intravenous, Intramuscular||Administered to a patient by the member in his or her office only in emergency circumstances with a maximum dose of 100 mg.|
|Epinephrine Hydrochloride||Intramuscular||Administered to a patient by the member in his or her office only in emergency circumstances with a maximum dose of 1.5 mg.|
|Ferrous Sulphate||Intramuscular||Must be administered by z-track only.|
|Folic Acid||Intravenous, Intramuscular||No limitation specified.|
|Glutamine||Intravenous||Must be in combination with other amino acids.|
|Glutamic Acid||Intravenous||Must be in combination with other amino acids.|
|Glycine||Intravenous||Must be in combination with other amino acids.|
|Glutathione||Intravenous, Intramuscular||No limitation specified.|
|Histidine||Intravenous||Must be in combination with other amino acids.|
|Hydrochloric Acid||Intravenous||In ratio of 1:1000 or 1:500.|
|Isoleucine||Intravenous||Must be in combination with other amino acids.|
|L-Tryptophan||Intravenous||No limitation specified.|
|Lactated Ringer’s Solution||Intravenous||No limitation specified.|
|Leucine||Intravenous||Must be in combination with other amino acids.|
|Levocarnitine and its salts||Intravenous||No limitation specified.|
|Lysine||Intravenous||Must be in combination with other amino acids.|
|Magnesium Sulfate||Intravenous, Intramuscular||Must never be administered by the member for the treatment of eclampsia or pre-eclampsia.|
|Magnesium Chloride||Intravenous, Intramuscular||Must never be administered by the member for the treatment of eclampsia or pre-eclampsia.|
|Manganese||Intravenous||No limitation specified.|
|Methionine||Intravenous||Must be in combination with other amino acids.|
|Molybdenum||Intravenous||No limitation specified.|
|Ornithine||Intravenous||Must be in combination with other amino acids.|
|Phenylalanine||Intravenous||Must be in combination with other amino acids.|
|Potassium Chloride||Intravenous||In dosage form not more than 0.3 mEq/kg/hr. Must never be administered as a single agent or by intravenous push.|
|Potassium Phosphate||Intravenous||In dosage form not more than 0.3 mEq/kg/hr. Must never be administered as a single agent or by intravenous push.|
|Proline||Intravenous||Must be in combination with other amino acids.|
|Ringer’s Solution (sodium, chloride, potassium and calcium)||Intravenous||No limitation specified.|
|Saline Solution||Intravenous, Intramuscular||No limitation specified.|
|Selenium||Intravenous||No limitation specified.|
|Serine||Intravenous||Must be in combination with other amino acids.|
|Sodium Bicarbonate||Intravenous||No limitation specified.|
|Sodium Iodide||Intravenous||Must be in combination with other minerals.|
|Sterile Water||Intravenous, Intramuscular||Must be in combination with other substances.|
|Strontium and its salts||Intravenous||No limitation specified.|
|Taurine||Intravenous||No limitation specified.|
|Threonine||Intravenous||Must be in combination with other amino acids.|
|Vanadium||Intravenous||Must be in combination with other minerals.|
|Viscum Album||Intravenous, Subcutaneous||No limitation specified.|
|Vitamin A||Intravenous||Maximum daily dose of 10,000 International Units.|
|Vitamin B1||Intravenous||No limitation specified.|
|Vitamin B2||Intravenous||No limitation specified.|
|Vitamin B3||Intravenous||No limitation specified.|
|Vitamin B5||Intravenous||No limitation specified.|
|Vitamin B6||Intravenous||No limitation specified.|
|Vitamin B12||Intravenous, Intramuscular||No limitation specified.|
|Vitamin C||Intravenous||Must administer no more than 15 g per day when patient’s G6PD is deficient.|
|Vitamin D||Intravenous, Intramuscular||No limitation specified.|
|Vitamin E||Intravenous||No limitation specified.|
|Vitamin K1||Intramuscular||No limitation specified.|
|Zinc Chloride||Intravenous||No limitation specified.|
|Zinc Sulphate||Intravenous||No limitation specified.|